LANRETULINE, created in 1993 (France), from 306 sister brands and 4958 competing brands. LANRETULINE is owned by Ipsen, listed on the stock exchange of Paris The ISIN, the company's International Securities Identification Number, is FR0010259150. LANRETULINE belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Ipsen
(LANRETULINE)
over 5 years*
EUR 122.85